Literature DB >> 3048804

One half of the CD11b+ human peripheral blood T lymphocytes coexpresses the S-100 protein.

C Ferrari1, P Sansoni, G Rowden, G C Manara, C Torresani, G De Panfilis.   

Abstract

The expression of the CD11b antigen and the presence of the S-100 (and, specifically, its beta subunit) protein within the T4- subpopulation of normal human peripheral blood lymphocytes were investigated by panning techniques, immunofluorescence analysis and immunoelectronmicroscopy. Both antigens are known to be absent in the T4+ lymphocytes. However, CD11b+ T lymphocytes represented about 30% of the T4- population; a part of them (over 1/3) belonged to and completely filled up the T4- T8- subpopulation, whereas the remaining part (almost 2/3) shared the T8 positivity. Interestingly, S-100+ T lymphocytes, which always were CD11b+ too, represented about one half of the CD11b+ T cells, but were excluded from the T4- T8- CD11b+ subpopulation, whereas they represented up to 80% of the T4- T8+ CD11b+ subset. Such findings demonstrate that the S-100+ T lymphocytes are exclusively restricted to a discrete T cell compartment which shows the T8+ CD11b+ immunophenotype. Since such T8+ CD11b+ cells had been shown to possess suppressive capabilities, we herein propose that S-100+ lymphocytes might to some extent modulate the immune responses. However, the exact functional significance of the S-100 protein still remains unknown.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3048804      PMCID: PMC1541574     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  "Panning" for lymphocytes: a method for cell selection.

Authors:  L J Wysocki; V L Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

2.  A soluble protein characteristic of the nervous system.

Authors:  B W Moore
Journal:  Biochem Biophys Res Commun       Date:  1965-06-09       Impact factor: 3.575

3.  Morphological heterogeneity of Leu7, Leu11 and OKM1 positive lymphocyte subsets: an ultrastructural study with the immunogold method.

Authors:  N Polli; E Matutes; D Robinson; D Catovsky
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

4.  S-100-positive T cells are largely restricted to a CD8-positive, 9.3-negative subset.

Authors:  P Sansoni; G Rowden; G C Manara; C Ferrari; G De Panfilis
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1987

5.  Characterization of a phenotypically distinct subpopulation of Leu-2+ cells that suppresses T cell proliferative responses.

Authors:  A Landay; G L Gartland; L T Clement
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

6.  Cutaneous histiocytosis X. The presence of S-100 protein and its use in diagnosis.

Authors:  G Rowden; E M Connelly; R K Winkelmann
Journal:  Arch Dermatol       Date:  1983-07

7.  S-100 antigen in human T lymphocytes.

Authors:  M Kanamori; T Endo; S Shirakawa; M Sakurai; H Hidaka
Journal:  Biochem Biophys Res Commun       Date:  1982-10-29       Impact factor: 3.575

8.  Single step separation of human T and B cells using AET treated srbc rosettes.

Authors:  A Saxon; J Feldhaus; R A Robins
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

9.  Two functionally distinct subpopulations of human T cells that collaborate in the generation of cytotoxic cells responsible for cell-mediated lympholysis.

Authors:  R L Evans; H Lazarus; A C Penta; S F Schlossman
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

10.  Characteristics of human large granular lymphocytes and relationship to natural killer and K cells.

Authors:  T Timonen; J R Ortaldo; R B Herberman
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

View more
  2 in total

1.  Enhancement of S-100 beta protein in blood of patients with Down's syndrome.

Authors:  K Kato; F Suzuki; N Kurobe; K Okajima; N Ogasawara; M Nagaya; T Yamanaka
Journal:  J Mol Neurosci       Date:  1990       Impact factor: 3.444

2.  The associations between serum vascular endothelial growth factor, tumor necrosis factor and interleukin 4 with the markers of blood-brain barrier breakdown in patients with paraneoplastic neurological syndromes.

Authors:  Slawomir Michalak; Alicja Kalinowska-Lyszczarz; Joanna Rybacka-Mossakowska; Mikolaj Zaborowski; Wojciech Kozubski
Journal:  J Neural Transm (Vienna)       Date:  2018-10-29       Impact factor: 3.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.